98%
921
2 minutes
20
Fine particulate matter (PM2.5) exposure can cause cardiovascular diseases (CVD) through cardiac fibrosis, but the underlying mechanisms driving this association are still unclear. Given the importance of endoplasmic reticulum stress (ERS), TXNIP, and pyroptosis in PM2.5-induced organ damage, we subsequently investigated their roles in PM2.5-induced cardiac fibrosis. To investigate the impact of PM2.5 on cardiac fibrosis in SPF C57BL/6 mice, we performed histopathology analysis on heart tissue exposed to varying PM2.5 dosages. Real-time PCR, commercial kits, and Western blotting are also being used to assess the degree of cardiac fibrosis in groups. In addition, the cardiac activation of the ERS/TXNIP/NLRP3 signaling pathway is examined. Significant fibrosis was observed in the heart tissue of mice that were exposed to high PM2.5 concentrations. The expression of key fibrosis markers and mediators was elevated, including α-SMA, CTGF, FN, and TGF-β1, along with the accumulation of ECM components (COL-I and COL-III). Compared to the control group, the PM2.5 was more intense, and Bip, PERK, p-PERK, CHOP, TXNIP, and ERS in the heart were all activated. Our findings demonstrate that PM2.5 exposure causes ERS and activates TXNIP in mice heart tissue. Further, the PM2.5 groups showed the raised expression of caspase-1, NLRP3, TXNIP, GSDMD-N, CRT, Caspase-3, and caspase-9. Our findings suggest that PM2.5 causes cardiac fibrosis by activating ERS, via TXNIP, inducing the activation of pyroptosis and apoptosis. The findings provide evidence that PM2.5-induced cardiac fibrosis through ERS-mediated activation of the CHOP/TXNIP/NLRP3 pathway, and provide insights into the underlying mechanisms of PM2.5-induced cardiac fibrosis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.intimp.2025.115073 | DOI Listing |
Clin Kidney J
September 2025
Department of Nephrology. University Clinical Hospital, INCLIVA, Valencia. RICORS Renal Instituto de salud Carlos III, Valencia. Spain.
Metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as a major contributor to systemic metabolic dysfunction and is increasingly recognized as a risk enhancer for both cardiovascular disease (CVD) and chronic kidney disease (CKD). This review explores the complex interconnections between MASLD, CVD, and CKD, with emphasis on shared pathophysiological mechanisms and the clinical implications for risk assessment and management. We describe the crosstalk among the liver, heart, and kidneys, focusing on insulin resistance, chronic inflammation, and progressive fibrosis as key mediators.
View Article and Find Full Text PDFRev Cardiovasc Med
August 2025
Department M3/Internal Medicine VI, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureş, 540142 Târgu Mureş, Romania.
Background: Epicardial adipose tissue (EAT) is an indicator of high cardiovascular and metabolic risk. This study aimed to investigate the association between EAT thickness (EATT) and liver fibrosis and steatosis in patients with type 2 diabetes mellitus (T2DM) and metabolic dysfunction-associated steatotic liver disease (MASLD).
Methods: Patients with T2DM and MASLD underwent a complex evaluation, which included clinical, laboratory, and liver and transthoracic cardiac ultrasound assessments.
Br J Pharmacol
September 2025
Department of Cardiology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Background And Purpose: Myocardial infarction (MI) is accompanied by acute release of numerous inflammatory factors, leading to fibrosis and ultimately cardiac dysfunction. Daucosterol (DAU), a natural sterol compound, has been demonstrated to have anti-inflammatory properties and the ability to mitigate liver fibrosis. This study aims to investigate the therapeutic potential of DAU in MI and explores the underlying mechanisms.
View Article and Find Full Text PDFLipids Health Dis
September 2025
Epidemiology, Medical Faculty, University of Augsburg, Stenglingstr. 2, Augsburg, 86156, Germany.
Background: This study aimed to investigate the gender-specific associations of skeletal muscle mass and fat mass with non-alcoholic fatty liver disease (NAFLD) and NAFLD-related liver fibrosis in two population-based studies.
Methods: Analyses were based on data from the MEGA (n = 238) and the MEIA study (n = 594) conducted between 2018 and 2023 in Augsburg, Germany. Bioelectrical impedance analysis was used to evaluate relative skeletal muscle mass (rSM) and SM index (SMI) as well as relative fat mass (rFM) and FM index (FMI); furthermore, the fat-to-muscle ratio was built.
Nat Cell Biol
September 2025
Department of Medicine, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Durotaxis, cell migration along stiffness gradients, is linked to embryonic development, tissue repair and disease. Despite solid in vitro evidence, its role in vivo remains largely speculative. Here we demonstrate that durotaxis actively drives disease progression in vivo in mouse models of lung fibrosis and metastatic pancreatic cancer.
View Article and Find Full Text PDF